Multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19, clinical characteristics: A

Marwan Shalabi1, Salam Ghanem2, Iyad Al-Ammouri3

  • 1Department of Pediatrics, School of Medicine, The Hashemite University, Amman, Jordan.

Global Epidemiology
|February 6, 2025
PubMed

Insights

Multisystem inflammatory syndrome in children (MIS-C) is a COVID-19 complication. This study of 74 Jordanian children found varied severity, with abdominal pain common, but no deaths occurred.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Multisystem inflammatory syndrome in children (MIS-C) is a serious condition linked to COVID-19.
  • Understanding MIS-C's clinical presentation and outcomes in diverse populations is crucial.

Purpose of the Study:

  • To describe the clinical course, management, and outcomes of MIS-C in Jordanian children.
  • To compare findings with global MIS-C data.

Main Methods:

  • A multicenter retrospective study of 74 children diagnosed with MIS-C in Jordan.
  • Data collected included clinical, laboratory, radiological, and therapeutic information.

Main Results:

  • Common symptoms included fever, abdominal pain, and hypoxia.
  • Cardiac involvement was infrequent and lacked coronary findings.
  • Treatments primarily involved Corticosteroids and IVIG; no mortality was observed, but some cases required Pediatric Intensive Care Unit admission.

Conclusions:

  • The clinical spectrum of MIS-C in Jordan mirrors global observations.
  • Abdominal pain was a prevalent symptom, sometimes leading to misdiagnosis as surgical emergencies.
  • While severe cases occurred, the overall outcome in this cohort was favorable, with no reported deaths.
Abstract

Related Concept Videos

Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
228
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
343
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
201